This week in science: understanding the differences between cyclones, typhoons, and hurricanes, a new perspective on ecosystems, a genetic link to overeating, and the surprising source of toxic microplastics. Read more...

Recent studies show a decline in US butterfly populations, narcissists experiencing social pain, and a genetic link to overeating in labradors and humans. Read more...

Weight loss jabs like Ozempic are linked to anxiety and social issues, prompting discussions about microdosing and natural alternatives for effective weight management. Read more...

Scientists develop an e-Taste device for virtual flavors. Meanwhile, Tropical Cyclone Alfred intensifies, threatening Brisbane with heavy winds and potential landfall. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Updates on Pope Francis's health following a respiratory crisis, alongside articles about sleep, weight gain, and the thyroid, plus a wellness leader's journey. Read more...

This week in health: a study on postpartum depression and brain changes, the risks of overhydration, and the potential pitfalls of weight-loss drugs like Ozempic. Plus, a ruling on cosmetic surgery. Read more...

This week in health news: discover top eye care brands, advancements in antibiotic treatment, the role of virtual medical assistants, and a guide to whey protein. Read more...

Israeli startups are making waves in healthcare, offering drug-free ED solutions, natural weight management alternatives, rapid infection diagnostics, and Ebola treatments. Read more...

Six cyclones raged in the Southern Hemisphere, while scientists unveil "e-Taste" for virtual reality, promising flavor experiences without the calories (or spice!). Read more...